Aspirin alters methotrexate disposition in rheumatoid arthritis patients

Arthritis & Rheumatism

Volumn 34, Issue 12, 1991, Pages 1514-1520

  Stewart, Clinton F ^a,c,d   Fleming, Ronald A ^a,c,d   Germain, Bernard F ^a,c,d   Seleznick, Mitchel J ^b,c,d   Evans, William E ^a,c,d  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; ADULT; ARTHRITIS, RHEUMATOID; ASPIRIN; BLOOD PROTEINS; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; METHOTREXATE; MIDDLE AGE; PROTEIN BINDING; SUPPORT, NON-U.S. GOV'T;

EID: 0026348698     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780341207     Document Type: Article

References (37)

1. The current status of methotrexate in rheumatic diseases
2. Intermittent high dose oral methotrexate therapy in psoriasis
3. Methotrexate therapy in psoriatic arthritis
4. Methotrexate: its use in the rheumatic diseases
5. Reiter's syndrome: treatment with methotrexate
6. Low‐dose pulse therapy in rheumatoid arthritis
7. Efficacy of low dose methotrexate in rheumatoid arthritis
8. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature
9. Methotrexate 1989: the evolving story
10. Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?
11. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid
12. Drug‐drug interactions with antirheumatic agents: review of selected clinically important interactions
13. The effect of organic acids on renal clearance of methotrexate in man
14. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
15. Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography
16. Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis
17. Importance of radiochemical purity of radiolabeled drugs used for determining plasma protein binding of drugs
18. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximations
19. Fatal interaction between methotrexate and naproxen (letter)
20. Clinical and pharmacokinetic evidence of a life‐threatening interaction between methotrexate and ketoprofen
21. Acute renal failure and death following sequential intermediate‐dose methotrexate and 5‐FU: a possible adverse effect due to concomitant indomethacin administration
22. Near fatal drug interactions with methotrexate given for psoriasis
23. Interaction between methotrexate and non‐steroidal antiinflammatory drugs (letter)
24. Methotrexate‐salicylate interaction: a clinical and experimental study
25. Coadministration of naproxen and low‐dose methotrexate in patients with rheumatoid arthritis
26. Effect of aspirin and sulindac on methotrexate clearance
27. Acute effects of acetylsalicylic acid on renal and hepatic function in normal humans
28. Effect of plasma protein binding on renal clearance of drugs
29. Theoretical limits of changes in plasma protein binding on renal drug clearance
30. 125I‐diatrizoate
31. Aspirin‐induced depression of renal function
32. Effects of aspirin on glomerular filtration rate in normal humans
33. Renal tubular transport of methotrexate in the Rhesus monkey and dog
34. Comparison of toxicity in methotrexate treated rheumatoid arthritis pts. also taking aspirin or other NSAID (abstract)